TY - JOUR AU - Blanchard, P. AU - Hill, C. AU - Guihenneuc-Jouyaux, C. AU - Baey, C. AU - Bourhis, J. AU - Pignon, J. P. PY - 2011 DA - 2011// TI - Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer JO - J Clin Epidemiol VL - 64 UR - https://doi.org/10.1016/j.jclinepi.2010.10.016 DO - 10.1016/j.jclinepi.2010.10.016 ID - Blanchard2011 ER - TY - JOUR AU - Mills, E. J. AU - Ioannidis, J. P. A. AU - Thorlund, K. AU - Schünemann, H. J. AU - Puhan, M. A. AU - Guyatt, G. H. PY - 2012 DA - 2012// TI - How to use an article reporting a multiple treatment comparison meta-analysis JO - JAMA VL - 308 UR - https://doi.org/10.1001/2012.jama.11228 DO - 10.1001/2012.jama.11228 ID - Mills2012 ER - TY - JOUR AU - Royston, P. AU - Parmar, M. K. PY - 2013 DA - 2013// TI - Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome JO - BMC Med Res Methodol VL - 13 UR - https://doi.org/10.1186/1471-2288-13-152 DO - 10.1186/1471-2288-13-152 ID - Royston2013 ER - TY - JOUR AU - A’Hern, R. P. PY - 2016 DA - 2016// TI - Restricted mean survival time: an obligatory end point for time-to-event analysis in cancer trials? JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2016.67.8045 DO - 10.1200/JCO.2016.67.8045 ID - A’Hern2016 ER - TY - JOUR AU - James, N. D. AU - Bono, J. S. AU - Spears, M. R. AU - Clarke, N. W. AU - Mason, M. D. AU - Dearnaley, D. P. PY - 2017 DA - 2017// TI - Abiraterone for prostate cancer not previously treated with hormone therapy JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1702900 DO - 10.1056/NEJMoa1702900 ID - James2017 ER - TY - JOUR AU - Dehbi, H. -. M. AU - Royston, P. AU - Hackshaw, A. PY - 2017 DA - 2017// TI - Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards JO - BMJ VL - 357 UR - https://doi.org/10.1136/bmj.j2250 DO - 10.1136/bmj.j2250 ID - Dehbi2017 ER - TY - JOUR AU - Royston, P. AU - Parmar, M. K. B. PY - 2011 DA - 2011// TI - The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt JO - Stat Med VL - 30 UR - https://doi.org/10.1002/sim.4274 DO - 10.1002/sim.4274 ID - Royston2011 ER - TY - JOUR AU - Uno, H. AU - Claggett, B. AU - Tian, L. AU - Inoue, E. AU - Gallo, P. AU - Miyata, T. PY - 2014 DA - 2014// TI - Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2014.55.2208 DO - 10.1200/JCO.2014.55.2208 ID - Uno2014 ER - TY - JOUR AU - Trinquart, L. AU - Jacot, J. AU - Conner, S. C. AU - Porcher, R. PY - 2016 DA - 2016// TI - Comparison of treatment effects measured by the hazard ratio and by the ratio of restricted mean survival times in oncology randomized controlled trials JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.64.2488 DO - 10.1200/JCO.2015.64.2488 ID - Trinquart2016 ER - TY - JOUR AU - Wei, Y. AU - Royston, P. AU - Tierney, J. F. AU - Parmar, M. K. B. PY - 2015 DA - 2015// TI - Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data JO - Stat Med VL - 34 UR - https://doi.org/10.1002/sim.6556 DO - 10.1002/sim.6556 ID - Wei2015 ER - TY - JOUR AU - Lueza, B. AU - Mauguen, A. AU - Pignon, J. -. P. AU - Rivero-Arias, O. AU - Bonastre, J. PY - 2016 DA - 2016// TI - Difference in restricted mean survival time for cost-effectiveness analysis using individual patient data meta-analysis: evidence from a case study JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0150032 DO - 10.1371/journal.pone.0150032 ID - Lueza2016 ER - TY - JOUR AU - Ruysscher, D. AU - Lueza, B. AU - Péchoux, C. AU - Johnson, D. H. AU - O’Brien, M. AU - Murray, N. PY - 2016 DA - 2016// TI - Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdw263 DO - 10.1093/annonc/mdw263 ID - Ruysscher2016 ER - TY - JOUR AU - Lacas, B. AU - Bourhis, J. AU - Overgaard, J. AU - Zhang, Q. AU - Grégoire, V. AU - Nankivell, M. PY - 2017 DA - 2017// TI - Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis JO - Lancet Oncol VL - 18 UR - https://doi.org/10.1016/S1470-2045(17)30458-8 DO - 10.1016/S1470-2045(17)30458-8 ID - Lacas2017 ER - TY - JOUR AU - Ribassin-Majed, L. AU - Marguet, S. AU - Lee, A. W. M. AU - Ng, W. T. AU - Ma, J. AU - Chan, A. T. C. PY - 2017 DA - 2017// TI - What is the best treatment of locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2016.67.4119 DO - 10.1200/JCO.2016.67.4119 ID - Ribassin-Majed2017 ER - TY - JOUR AU - Blanchard, P. AU - Lee, A. AU - Marguet, S. AU - Leclercq, J. AU - Ng, W. T. AU - Ma, J. PY - 2015 DA - 2015// TI - Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)70126-9 DO - 10.1016/S1470-2045(15)70126-9 ID - Blanchard2015 ER - TY - STD TI - Brown J, Byron W, Hollander M, Korwar RM. Nonparametric tests of Independence for censored data with application to heart transplant studies. Reliab Biometry Stat Anal Lifelength. 1974:327–54. https://apps.dtic.mil/dtic/tr/fulltext/u2/767617.pdf. UR - https://apps.dtic.mil/dtic/tr/fulltext/u2/767617.pdf ID - ref16 ER - TY - JOUR AU - Lueza, B. AU - Rotolo, F. AU - Bonastre, J. AU - Pignon, J. -. P. AU - Michiels, S. PY - 2016 DA - 2016// TI - Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis JO - BMC Med Res Methodol VL - 16 UR - https://doi.org/10.1186/s12874-016-0137-z DO - 10.1186/s12874-016-0137-z ID - Lueza2016 ER - TY - JOUR AU - Higgins, J. P. T. AU - Thompson, S. G. PY - 2002 DA - 2002// TI - Quantifying heterogeneity in a meta-analysis JO - Stat Med VL - 21 UR - https://doi.org/10.1002/sim.1186 DO - 10.1002/sim.1186 ID - Higgins2002 ER - TY - JOUR AU - Grambsch, P. M. AU - Therneau, T. M. PY - 1994 DA - 1994// TI - Proportional hazards tests and diagnostics based on weighted residuals JO - Biometrika VL - 81 UR - https://doi.org/10.1093/biomet/81.3.515 DO - 10.1093/biomet/81.3.515 ID - Grambsch1994 ER - TY - JOUR AU - Rücker, G. PY - 2012 DA - 2012// TI - Network meta-analysis, electrical networks and graph theory JO - Res Synth Methods VL - 3 UR - https://doi.org/10.1002/jrsm.1058 DO - 10.1002/jrsm.1058 ID - Rücker2012 ER - TY - JOUR AU - Rücker, G. AU - Schwarzer, G. PY - 2015 DA - 2015// TI - Ranking treatments in frequentist network meta-analysis works without resampling methods JO - BMC Med Res Methodol VL - 15 UR - https://doi.org/10.1186/s12874-015-0060-8 DO - 10.1186/s12874-015-0060-8 ID - Rücker2015 ER - TY - JOUR AU - Hutton, B. AU - Salanti, G. AU - Caldwell, D. M. AU - Chaimani, A. AU - Schmid, C. H. AU - Cameron, C. PY - 2015 DA - 2015// TI - The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations JO - Ann Intern Med VL - 162 UR - https://doi.org/10.7326/M14-2385 DO - 10.7326/M14-2385 ID - Hutton2015 ER - TY - STD TI - netmeta package | R Documentation. https://www.rdocumentation.org/packages/netmeta/versions/0.9-5. Accessed 8 June 2017. UR - https://www.rdocumentation.org/packages/netmeta/versions/0.9-5 ID - ref23 ER - TY - JOUR PY - 1996 DA - 1996// TI - Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival JO - Int J Radiat Oncol Biol Phys VL - 35 ID - ref24 ER - TY - JOUR AU - Al-Sarraf, M. AU - LeBlanc, M. AU - Giri, P. G. AU - Fu, K. K. AU - Cooper, J. AU - Vuong, T. PY - 1998 DA - 1998// TI - Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099 JO - J Clin Oncol VL - 16 UR - https://doi.org/10.1200/JCO.1998.16.4.1310 DO - 10.1200/JCO.1998.16.4.1310 ID - Al-Sarraf1998 ER - TY - JOUR AU - Chi, K. -. H. AU - Chang, Y. -. C. AU - Guo, W. -. Y. AU - Leung, M. -. J. AU - Shiau, C. -. Y. AU - Chen, S. -. Y. PY - 2002 DA - 2002// TI - A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients JO - Int J Radiat Oncol Biol Phys VL - 52 UR - https://doi.org/10.1016/S0360-3016(01)02781-X DO - 10.1016/S0360-3016(01)02781-X ID - Chi2002 ER - TY - JOUR AU - Kwong, D. L. W. AU - Sham, J. S. T. AU - Au, G. K. H. AU - Chua, D. T. T. AU - Kwong, P. W. K. AU - Cheng, A. C. K. PY - 2004 DA - 2004// TI - Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.05.173 DO - 10.1200/JCO.2004.05.173 ID - Kwong2004 ER - TY - JOUR AU - Wee, J. AU - Tan, E. H. AU - Tai, B. C. AU - Wong, H. B. AU - Leong, S. S. AU - Tan, T. PY - 2005 DA - 2005// TI - Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.16.790 DO - 10.1200/JCO.2005.16.790 ID - Wee2005 ER - TY - JOUR AU - Lee, A. W. M. AU - Tung, S. Y. AU - Chua, D. T. T. AU - Ngan, R. K. C. AU - Chappell, R. AU - Tung, R. PY - 2010 DA - 2010// TI - Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma JO - J Natl Cancer Inst VL - 102 UR - https://doi.org/10.1093/jnci/djq258 DO - 10.1093/jnci/djq258 ID - Lee2010 ER - TY - JOUR AU - Lee, A. W. M. AU - Tung, S. Y. AU - Chan, A. T. C. AU - Chappell, R. AU - Fu, Y. -. T. AU - Lu, T. -. X. PY - 2011 DA - 2011// TI - A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma JO - Radiother Oncol VL - 98 UR - https://doi.org/10.1016/j.radonc.2010.09.023 DO - 10.1016/j.radonc.2010.09.023 ID - Lee2011 ER - TY - JOUR AU - Wu, X. AU - Huang, P. Y. AU - Peng, P. J. AU - Lu, L. X. AU - Han, F. AU - Wu, S. X. PY - 2013 DA - 2013// TI - Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mdt163 DO - 10.1093/annonc/mdt163 ID - Wu2013 ER - TY - JOUR AU - Hui, E. P. AU - Ma, B. B. AU - Leung, S. F. AU - King, A. D. AU - Mo, F. AU - Kam, M. K. PY - 2009 DA - 2009// TI - Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.1545 DO - 10.1200/JCO.2008.18.1545 ID - Hui2009 ER - TY - JOUR AU - Huang, P. -. Y. AU - Cao, K. -. J. AU - Guo, X. AU - Mo, H. -. Y. AU - Guo, L. AU - Xiang, Y. -. Q. PY - 2012 DA - 2012// TI - A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma JO - Oral Oncol VL - 48 UR - https://doi.org/10.1016/j.oraloncology.2012.04.006 DO - 10.1016/j.oraloncology.2012.04.006 ID - Huang2012 ER - TY - JOUR AU - Chen, Y. AU - Sun, Y. AU - Liang, S. -. B. AU - Zong, J. -. F. AU - Li, W. -. F. AU - Chen, M. PY - 2013 DA - 2013// TI - Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China JO - Cancer VL - 119 UR - https://doi.org/10.1002/cncr.28049 DO - 10.1002/cncr.28049 ID - Chen2013 ER - TY - JOUR AU - Chen, Q. -. Y. AU - Wen, Y. -. F. AU - Guo, L. AU - Liu, H. AU - Huang, P. -. Y. AU - Mo, H. -. Y. PY - 2011 DA - 2011// TI - Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial JO - J Natl Cancer Inst VL - 103 UR - https://doi.org/10.1093/jnci/djr432 DO - 10.1093/jnci/djr432 ID - Chen2011 ER - TY - JOUR AU - Fountzilas, G. AU - Ciuleanu, E. AU - Bobos, M. AU - Kalogera-Fountzila, A. AU - Eleftheraki, A. G. AU - Karayannopoulou, G. PY - 2012 DA - 2012// TI - Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mdr116 DO - 10.1093/annonc/mdr116 ID - Fountzilas2012 ER - TY - JOUR AU - Chen, L. AU - Hu, C. -. S. AU - Chen, X. -. Z. AU - Hu, G. -. Q. AU - Cheng, Z. -. B. AU - Sun, Y. PY - 2012 DA - 2012// TI - Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(11)70320-5 DO - 10.1016/S1470-2045(11)70320-5 ID - Chen2012 ER - TY - JOUR AU - Xu, T. AU - Zhu, G. AU - He, X. AU - Ying, H. AU - Hu, C. PY - 2014 DA - 2014// TI - A phase III randomized study comparing neoadjuvant chemotherapy with concurrent chemotherapy combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma: updated long-term survival outcomes JO - Oral Oncol VL - 50 UR - https://doi.org/10.1016/j.oraloncology.2013.11.002 DO - 10.1016/j.oraloncology.2013.11.002 ID - Xu2014 ER - TY - JOUR AU - Chan, A. T. AU - Teo, P. M. AU - Leung, T. W. AU - Leung, S. F. AU - Lee, W. Y. AU - Yeo, W. PY - 1995 DA - 1995// TI - A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma JO - Int J Radiat Oncol Biol Phys VL - 33 UR - https://doi.org/10.1016/0360-3016(95)00218-N DO - 10.1016/0360-3016(95)00218-N ID - Chan1995 ER - TY - JOUR AU - Chua, D. T. AU - Sham, J. S. AU - Choy, D. AU - Lorvidhaya, V. AU - Sumitsawan, Y. AU - Thongprasert, S. PY - 1998 DA - 1998// TI - Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group JO - Cancer VL - 83 UR - https://doi.org/3.0.CO;2-T DO - 3.0.CO;2-T ID - Chua1998 ER - TY - JOUR AU - Hareyama, M. AU - Sakata, K. AU - Shirato, H. AU - Nishioka, T. AU - Nishio, M. AU - Suzuki, K. PY - 2002 DA - 2002// TI - A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma JO - Cancer VL - 94 UR - https://doi.org/10.1002/cncr.10473 DO - 10.1002/cncr.10473 ID - Hareyama2002 ER - TY - JOUR AU - Chan, A. T. C. AU - Leung, S. F. AU - Ngan, R. K. C. AU - Teo, P. M. L. AU - Lau, W. H. AU - Kwan, W. H. PY - 2005 DA - 2005// TI - Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma JO - J Natl Cancer Inst VL - 97 UR - https://doi.org/10.1093/jnci/dji084 DO - 10.1093/jnci/dji084 ID - Chan2005 ER - TY - STD TI - Rotolo F, Pignon J-P, Bourhis J, Marguet S, Leclercq J, Tong Ng W, et al. Surrogate end points for overall survival in loco-regionally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis. J Natl Cancer Inst. 2017;109. https://doi.org/10.1093/jnci/djw239. ID - ref43 ER - TY - JOUR AU - Lamb, K. E. AU - Williamson, E. J. AU - Coory, M. AU - Carlin, J. B. PY - 2015 DA - 2015// TI - Bias and precision of measures of survival gain from right-censored data JO - Pharm Stat VL - 14 UR - https://doi.org/10.1002/pst.1700 DO - 10.1002/pst.1700 ID - Lamb2015 ER - TY - JOUR AU - Royston, P. AU - Parmar, M. K. B. PY - 2002 DA - 2002// TI - Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects JO - Stat Med VL - 21 UR - https://doi.org/10.1002/sim.1203 DO - 10.1002/sim.1203 ID - Royston2002 ER - TY - JOUR AU - Freeman, S. u. z. a. n. n. e. C. AU - Carpenter, J. a. m. e. s. R. PY - 2017 DA - 2017// TI - Bayesian one-step IPD network meta-analysis of time-to-event data using Royston-Parmar models JO - Research Synthesis Methods VL - 8 UR - https://doi.org/10.1002/jrsm.1253 DO - 10.1002/jrsm.1253 ID - Freeman2017 ER - TY - STD TI - Calkins KL, Canan CE, Moore RD, Lesko CR, Lau B. An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use. BMC Med Res Methodol. 2018;18. https://doi.org/10.1186/s12874-018-0484-z. ID - ref47 ER - TY - JOUR AU - Ouwens, M. J. N. M. AU - Philips, Z. AU - Jansen, J. P. PY - 2010 DA - 2010// TI - Network meta-analysis of parametric survival curves JO - Res Synth Methods VL - 1 UR - https://doi.org/10.1002/jrsm.25 DO - 10.1002/jrsm.25 ID - Ouwens2010 ER - TY - JOUR AU - Uno, H. AU - Wittes, J. AU - Fu, H. AU - Solomon, S. D. AU - Claggett, B. AU - Tian, L. PY - 2015 DA - 2015// TI - Alternatives to hazard ratios for comparing the efficacy or safety of therapies in noninferiority studies JO - Ann Intern Med VL - 163 UR - https://doi.org/10.7326/M14-1741 DO - 10.7326/M14-1741 ID - Uno2015 ER -